MarketGrader Europe 100 Index


Five Largest Companies
Symbol Name Grade Market Cap Country
ASML.NL ASML Holding NV 62.5 $526,573 NL
HSBA.GB HSBC Holdings Plc 48.3 $298,667 GB
AZN.GB AstraZeneca PLC 68.7 $295,026 GB
NOVN.CH Novartis AG 58.3 $293,336 CH
SAP.DE SAP SE 61.4 $229,386 DE

Five Smallest Companies
Symbol Name Grade Market Cap Country
BIM.FR bioMerieux SA 50.2 $13,604 FR
ENX.FR Euronext NV 55.5 $13,804 NL
SN.GB Smith & Nephew plc 59.8 $14,945 GB
PNR Pentair plc 51.1 $15,541 GB
SOON.CH Sonova Holding AG 48.7 $16,041 CH

Companies with Most Selections Among Current Components
Symbol Name Grade Times* Country
ASML.NL ASML Holding NV 62.5 33 NL
ACN Accenture Plc Class A 59.6 32 IE
DNB.NO DNB Bank ASA 62.1 29 NO
ALV.DE Allianz SE 54.4 28 DE
LR.FR Legrand SA 55.7 28 FR
NOVO.B.DK Novo Nordisk A/S Class B 55.1 28 DK
ASSA.B.SE ASSA ABLOY AB Class B 48.8 27 SE
TEL TE Connectivity plc 65.6 26 IE
ETN Eaton Corp. Plc 59.5 25 IE
SAND.SE Sandvik AB 51.6 24 SE
*Number of times selected at Index semi-annual reconstitutions since inception date.
Index Bio
Average Market Cap $76,702
Median Market Cap $45,023
Avg. 3 Mo. Dollar Vol. $167,928,969
Avg. 3 Mo. Trading Vol. 5,321,627
Last Rebalance Date 09/22/2025
Companies Replaced 49
Biggest Sector Increase Health Care
Biggest Sector Decrease Utilities

Fundamental Attributes
Trailing P/E Ratio (12 Mo.) 17.6
Forward P/E Ratio (12 Mo.) 15.4
Price/Book Ratio 3.2
Avg. Revenue Chg. - 3 Yr 24.1%
Avg. Op. Income Chg. - 3 Yr. 55.2%
Avg. EPS Growth - 3 Yr. 16.9%
Avg. EPS Growth - 1 Yr. 19.6%
Avg. Operating Margin 19.8%
Avg. LT Debt to Total Capital 41.4%
Avg. Return on Equity 16.9%
Dividend Yield 1.8%
Index Average Grade
Europe 100 Index 58.06
Country Breakdown
United Kingdom 22.0%
Germany 14.0%
Switzerland 10.0%
Ireland 10.0%
Netherlands 9.0%
Sweden 7.0%
France 7.0%
Italy 6.0%
Spain 5.0%
Denmark 2.0%
Belgium 2.0%
Norway 2.0%
Luxembourg 1.0%
Hong Kong 1.0%
Austria 1.0%
Finland 1.0%
For more information on this index please contact us

Get Access to the World's Smartest Global Research Platform

Don't wait another day to make better informed, higher-returning investments.

TRY IT FOR FREE